These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9649948)

  • 1. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy.
    Lunetta M; Le Moli R; Grasso G; Sangiorgio L
    Diabetes Res Clin Pract; 1998 Mar; 39(3):165-72. PubMed ID: 9649948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A; Bakhshipour A; Rashidi H
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].
    Jia WP; Shen Q; Bao YQ; Lu JX; Li M; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2707-10. PubMed ID: 17199983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy].
    Hu H; Li H; Zheng FP; Cheng Y; Miao J; Zhang W
    Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):13-7. PubMed ID: 22490752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument.
    Barbosa M; Saavedra A; Severo M; Maier C; Carvalho D
    Pain Pract; 2017 Apr; 17(4):514-521. PubMed ID: 27538385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.
    Feldman EL; Stevens MJ; Thomas PK; Brown MB; Canal N; Greene DA
    Diabetes Care; 1994 Nov; 17(11):1281-9. PubMed ID: 7821168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Value of Neuropathy Symptom and Change Score, Neuropathy Impairment Score and Michigan Neuropathy Screening Instrument for Diabetic Peripheral Neuropathy.
    Xiong Q; Lu B; Ye H; Wu X; Zhang T; Li Y
    Eur Neurol; 2015; 74(5-6):323-7. PubMed ID: 26684759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds.
    Bax G; Fagherazzi C; Piarulli F; Nicolucci A; Fedele D
    Diabetes Care; 1996 Aug; 19(8):904-5. PubMed ID: 8842620
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
    Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
    Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy.
    Oh TJ; Song Y; Jang HC; Choi SH
    Diabetes Metab J; 2022 Mar; 46(2):319-326. PubMed ID: 34525791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cultural adaptation to Brazilian Portuguese of the Michigan Neuropathy Screening Instrument: MNSI-Brazil.
    Oliveira FB; Botelho KK; Bezerra AR; Azevedo DI; Santos-Couto-Paz CC; Fachin-Martins E
    Arq Neuropsiquiatr; 2016 Aug; 74(8):653-61. PubMed ID: 27556378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of obesity on the assessment of diabetic peripheral neuropathy: a comparison of Michigan patient version test and Michigan physical assessment.
    Boyraz O; Saracoglu M
    Diabetes Res Clin Pract; 2010 Dec; 90(3):256-60. PubMed ID: 20943282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study.
    Kaymaz S; Alkan H; Karasu U; Çobankara V
    Diabetol Int; 2020 Jul; 11(3):283-292. PubMed ID: 32802710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation, validation, and diagnostic accuracy of the Arabic version of the Michigan neuropathy screening instrument.
    Abuzinadah AR; Alkully HS; Alanazy MH; Alrawaili MS; Milyani HA; AlAmri B; AlShareef AA; Bamaga AK
    Medicine (Baltimore); 2021 Nov; 100(44):e27627. PubMed ID: 34871227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and reliability of the Turkish version of the Michigan Neuropathy Screening Instrument.
    Aktar Reyhanioğlu D; Adiyaman SC; Bektaş M; Bulut O; Özgen Saydam B; Bayraktar F; Kara B
    Turk J Med Sci; 2020 Jun; 50(4):789-797. PubMed ID: 32178509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early identification of peripheral neuropathy based on sudomotor dysfunction in Mexican patients with type 2 diabetes.
    Carbajal-Ramírez A; Hernández-Domínguez JA; Molina-Ayala MA; Rojas-Uribe MM; Chávez-Negrete A
    BMC Neurol; 2019 May; 19(1):109. PubMed ID: 31151430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the Diagnosis of Diabetic Peripheral Neuropathy Among People with Type 2 Diabetes-A Study from South India.
    Viswanathan V; Ahmed Khan B; Nachimuthu S; Kumpatla S
    Int J Low Extrem Wounds; 2023 Mar; ():15347346231163209. PubMed ID: 36924005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation and Psychometric Properties of the Arabic Version of Michigan Neuropathy Screening Instrument in Type 2 Diabetes.
    Mohammad MT; Muhaidat J; Momani MS; Al-Khlaifat L; Okasheh R; Qutishat D; Al-Yahya E
    J Diabetes Res; 2019; 2019():2673105. PubMed ID: 31049355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.